Skip to Main Content

Paper Details

Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins.
Cancer Res Commun
0
2023
DNA repair proteins, IFN gamma, PBP, PBP signature, PBPs, Purine, Purine-binding Proteins, TNBC, Triple-negative Breast Cancer, Triple-negative breast cancer, breast tumors, carboplatin, docetaxel, mRNA, pCR, patients, purine, purine-binding proteins, seven-gene, tumor
Author NameAffiliation
Alexander B SaltzmanBaylor College of Medicine
Eric J JaehnigLester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Eric J JaehnigLester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Jonathan T LeiLester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Anna MalovannayaBaylor College of Medicine
Anna MalovannayaBaylor College of Medicine
Mothaffar F RimawiLester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Foluso O AdemuyiwaSiteman Comprehensive Cancer Center and Washington University School of Medicine
Meenakshi AnuragLester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Meenakshi AnuragBaylor College of Medicine
Beom-Jun KimLester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Beom-Jun Kim
Beom-Jun KimLester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Beom-Jun Kim
Matthew J EllisLester and Sue Smith Breast Center and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Matthew J Ellis
  • 1 - 16

Datasets

Release 1.2